Targeted consultations address the need for personalized care in specialty pharmacy programs
As oral oncolytic therapies replace traditional intravenous chemotherapy treatment methods, new complexities around driving patient adherence and persistence, minimizing medication-medication/food-medication interactions, and more all impact patients during the most vulnerable of times. Specialty pharmacy programs have become increasingly complicated with no signs of stopping.
From complex multi-medication regimens to understanding proper administration and navigating the uncertainties of these high-cost medications, several barriers exist in preventing patients from being their healthiest. Combine this with the fact that the treatment of cancer continues to evolve rapidly, and the need for strong patient engagement and highly coordinated, team-based care has never been greater.
But it doesn’t have to be.
Advantages of a pharmacist-led approach
Aspen RxHealth pharmacists don’t fill patient prescriptions. Regardless of where the patient fills their prescription, we focus our solutions on providing tailored and timely patient care based on the specific disease state and the patient and provider’s shared goals. We customize engagement and education strategies based on our client’s unique needs, with a robust nationwide community of over 7,000 pharmacists designed to focus specifically on patients’ clinical vulnerabilities.
We deliver these interventions based on an agreed-upon cadence, with the most relevant and meaningful messaging, and subsequent educational needs/follow-ups as part of a more comprehensive care team. Our pharmacists can then align their care plans in accordance with the patient’s labs, scans, physician’s notes and in collaboration with physicians, ARNP/NP, and nurses.
As new medications enter the market, the need for pharmacist-led care in oral oncolytics is critical now more than ever. Aspen RxHealth’s inventive model was developed to meet the needs of a wide array of members and patients – with the intent of driving improved adherence rates that outperform traditional benchmarks, as well as superior patient experience.
Together, we can simplify the usage of the most complex medications.
